Latest filing published 01 Oct 2026 for Xeris Biopharma Holdings, Inc., €141k.
No signal scores available.
This profile gathers the share dealings of Beth Hecht in Xeris Biopharma Holdings, Inc. The record holds 2 filings, for trades running from 1 July 2026 to 1 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 1 October 2026: a transaction of €141k, in Xeris Biopharma Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations